|
Market Cap (3-Jul) $8,006,598,144 (204th) |
Close (30-Jun) $11.22 |
Volume (30-Jun) 664,557 |
Shortsold (19-Jun) 16,724,445 (4.94%) (48th) |
|
52w High $31.97 |
52w Low $17.03 |
P/E 56.82 |
EPS 0.14 |
TLX released this announcement to the ASX on 3 November 2020, 9:35. The announcement is not marked as price sensitive, and is 15 page(s) in length and 225.14kb in size.
You can view all announcements from TLX and see how they appear on a price chart on the announcements page.
At the date of this announcement, TLX was 0.065% short sold according to ASIC data. It was ranked the 437th most shorted stock on the ASX. It is now ranked as the 48th most shorted stock on the ASX with 4.944% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from TLX | |
|---|---|
| Cleansing Notice | 28 June 2023, 8:23 |
| Application for quotation of securities - TLX | 28 June 2023, 8:23 |
| Proposed issue of securities - TLX | 21 June 2023, 18:12 |
| Appendix 2A - issue of shares on exercise of options | 3 November 2020, 9:35 |
| Investor Briefing - Asia Strategy | 3 November 2020, 8:21 |
| Investor Call - Strategic Licence and Commercial Partnership | 2 November 2020, 14:21 |
| Appendix 3B - Proposed Issue of Securities | 2 November 2020, 14:20 |
You must be logged in to post a reply.
Telix Pharmaceuticals 